Ronald M. Lombardi Sells 10,875 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) Stock

Prestige Consumer Healthcare Inc. (NYSE:PBH) CEO Ronald M. Lombardi sold 10,875 shares of the business’s stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total transaction of $898,275.00. Following the transaction, the chief executive officer now owns 320,952 shares of the company’s stock, valued at approximately $26,510,635.20. The trade was a 3.28 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Prestige Consumer Healthcare Stock Up 0.8 %

Prestige Consumer Healthcare stock opened at $84.85 on Friday. The company has a market capitalization of $4.19 billion, a P/E ratio of 20.46, a PEG ratio of 2.32 and a beta of 0.47. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.10 and a current ratio of 3.56. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $85.22. The stock has a 50-day simple moving average of $74.13 and a 200-day simple moving average of $70.57.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.09. The company had revenue of $283.79 million during the quarter, compared to analysts’ expectations of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm’s revenue for the quarter was down .9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.07 earnings per share. Equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC purchased a new position in shares of Prestige Consumer Healthcare during the first quarter worth about $218,000. State Board of Administration of Florida Retirement System grew its stake in shares of Prestige Consumer Healthcare by 77.4% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock valued at $1,830,000 after purchasing an additional 11,000 shares during the last quarter. Covestor Ltd increased its holdings in shares of Prestige Consumer Healthcare by 21.6% in the first quarter. Covestor Ltd now owns 834 shares of the company’s stock valued at $61,000 after purchasing an additional 148 shares during the period. O Shaughnessy Asset Management LLC raised its stake in shares of Prestige Consumer Healthcare by 16.3% during the first quarter. O Shaughnessy Asset Management LLC now owns 6,662 shares of the company’s stock worth $483,000 after purchasing an additional 936 shares during the last quarter. Finally, UniSuper Management Pty Ltd acquired a new stake in shares of Prestige Consumer Healthcare during the first quarter worth $760,000. 99.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PBH has been the subject of several analyst reports. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson reaffirmed a “buy” rating and issued a $95.00 price target on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, Prestige Consumer Healthcare has a consensus rating of “Moderate Buy” and an average target price of $83.67.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.